1) ATTARDI ENRICO:
Progetto di Ricerca:
- Policlinico Tor Vergata – UOSD Diagnostica avanzata oncoematologica (dal 20/07/2022 al 31/10/2022);
- Membro del Team AIRC 5x1000.
Mobilità:
- Progetti EU,EHA2022 Hybrid Congress (Austria dal 09/06/2022 al 12/06/2022);
Pubblicazioni:
-" LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence ", Calabretto, G., Attardi, E., Gurnari, C., ...Voso, M.T., Zambello, R., Cancers, 2022, 14(21), 5236;
-" Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience ", Calabretto, G., Attardi, E., Teramo, A., ...Zambello, R., Santini, V.,Leukemia, 2022, 36(7), pp. 1947–1950;
- "Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study ",Schiavo, E., Martini, B., Attardi, E., ...Favre, C., Gambineri, E., Frontiers in Immunology, 2022, 12, 790455
- " An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone ", Borsellino, B., Savi, A., Pascale, M.R., ...Buccisano, F., Voso, M.T.,Mediterranean Journal of Hematology and Infectious Diseases, 2022, 14(1), e2022058;
-" Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study ", Attardi, E., Pilerci, S., Attucci, I., ...Vannucchi, A.M., Antonioli, E., Clinical Lymphoma, Myeloma and Leukemia, 2021, 21(11), pp. e850–e852;
2) MATTEOCCI ALESSANDRO:
Pubblicazioni:
- " Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We? " , Chiurchiù, V., Tiberi, M., Matteocci, A., ...Mercuri, N.B., Sancesario, G., International Journal of Molecular Sciences, 2022, 23(11), 6235;
- " Macrophage plasticity and polarization are altered in the experimental model of multiple sclerosis", Leuti, A., Talamonti, E., Gentile, A., ...Centonze, D., Chiurchiù, V., Biomolecules, 2021, 11(6), 837;
3) SERRA MARTINA:
Progetto di Ricerca :
- Regina Elena National Cancer Institute of Rome (IRE-IFO) dal 01/06/2022 al 31/10/2022;
Pubblicazioni:
- " miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells ", Regis, S., Dondero, A., Spaggiari, G.M., ...Bottino, C., Castriconi, R., Cellular Signalling, 2022, 98, 110415;
- " Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants ", Dondero, A., Morini, M., Cangelosi, D., ...Bottino, C., Castriconi, R., Journal for ImmunoTherapy of Cancer, 2021, 9(4), e002293;
- " Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells ", Cantoni, C., Serra, M., Parisi, E., ...Ghiggeri, G.M., Spaggiari, G.M., OncoImmunology, 2021, 10(1),1879530;
4) SILVESTRINI GIORGIA:
Attività:
- Membro del Team AIRC 5x1000.
Pubblicazioni:
- " The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia ", S Travaglini 1, C Gurnari 1 2, S Antonelli 1, G Silvestrini 1, N I Noguera 1 3, T Ottone 1 3, M T Voso 1 3 ,PMID: 35938170
PMCID: PMC9352950, DOI: 10.3389/fcell.2022.930205;
1) CATANOSO MARIALUIGIA:
Attività:
- Progetto di Ricerca presso Ospedale Bambino Gesù ( dal 01/01/21 al 31/10/21);
Pubblicazioni:
- " Signaling Crosstalks Drive Generation and Regeneration of the Thymus ", Rosichini, M., Catanoso, M., Screpanti, I., ...Locatelli, F., Velardi, E., Frontiers in Immunology, 2022, 13, 920306;
- " Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells ", Di Paola, A., Palumbo, G., Tortora, C., ...Locatelli, F., Rossi, F., British Journal of Haematology, 2022, 197(1), pp. 110–119;
- " NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation ", Merli, P., Eichholz, T., Catanoso, M.L., Lang, P., Locatelli, F. , Stem Cell Reports, 2022, 17(3), pp. 443–445;
- " Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies ", Guercio, M., Manni, S., Boffa, I., ...Quintarelli, C., Locatelli, F., Frontiers in Immunology, 2021,12, 755639;
-" Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells " Cassandri, M., Pomella, S., Rossetti, A., ...Rota, R., Marampon, F., International Journal of Molecular Sciences, 2021, 22(19), 10671;
2) CEGLIE GIULIA:
Mobilità:
- Progetto EU presso Genethon/Università di Evry ,Francia (dal 01/04/21 al 01/10/21);
Pubblicazioni:
- " Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience ", De Ioris, M.A., Scarselli, A., Bracaglia, C., ...Mastronuzzi, A., De Vito, R., Pediatric Blood and Cancer, 2022, 69(11), e29919;
- " GATA 2 Deficiency: Focus on Immune System Impairment ", Fabozzi, F., Mastronuzzi, A., Ceglie, G., Masetti, R., Leardini, D., Frontiers in Immunology, 2022, 13, 865773;
- " Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30+ lymphoproliferative disorder: A case report " , Ceglie, G., De Vito, R., Cossutta, M., ...Boccieri, E., Palumbo, G., Pediatric Blood and Cancer, 2022, 69(6), e29626;
- " Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells ", Di Paola, A., Palumbo, G., Tortora, C., ...Locatelli, F., Rossi, F.,British Journal of Haematology, 2022, 197(1), pp. 110–119;
- " Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience ", Ceglie, G., Musolino, A., Clemente, V., ...Paganelli, V., Palumbo, G., Pediatric Hematology and Oncology, 2022;
- " Immune thrombocytopenia in a child with COVID-19: Is it the calm after the (cytokine) storm? ", Ceglie, G., De Ioris, M.A., Mercadante, S., ...Pianese, J., Palumbo, G., Pediatric Blood and Cancer, 2022, 69(1), e29326;
- " Immune thrombocytopenia in two infant cases managed with eltrombopag ", Ceglie, G., Nocentini, G., De Gennaro, F., ...Di Mauro, M., Palumbo, G., Pediatric Blood and Cancer, 2021, 68(9), e29120;
3) CONSIGLIERI GIULIA:
Pubblicazioni:
- " Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency ", Barzaghi, F., Cicalese, M.P., Zoccolillo, M., ...Mortellaro, A., Aiuti, A., Frontiers in Immunology, 2022, 13, 910021;
- " Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art ", Consiglieri, G., Bernardo, M.E., Brunetti-Pierri, N., Aiuti, A., Hematology/Oncology Clinics of North America, 2022, 36(4), pp. 865–878;
- " A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation ", Consiglieri, G., Ferrua, F., Brianti, P., ...Aiuti, A., Cicalese, M.P., Journal of Clinical Immunology, 2022, 42(2), pp. 421–425;
- " Correction to: A Case of Two Adult Brothers with Wiskott Aldrich Syndrome, One Treated with Gene Therapy and One with HLA Identical Hematopoietic Stem Cell Transplantation ", (42, 2, (421-425), 10.1007/s10875-021-01157-6) Consiglieri, G., Ferrua, F., Aiuti, A., Cicalese, M.P., Journal of Clinical Immunology, 2022, 42(2), pp. 426;
- " Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System ", Pontesilli, S., Baldoli, C., Rosa, P.A.D., ...Rovelli, A., Parini, R., Journal of Pediatrics, 2022, 240, pp. 297–301.e5;
- " Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome ", Gentner, B., Tucci, F., Galimberti, S., ...Aiuti, A., Bernardo, M.-E., New England Journal of Medicine, 2021, 385(21), pp. 1929–1940;
- " Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series ", Canarutto, D., Tucci, F., Gattillo, S., ...Bernardo, M.E., Aiuti, A., Molecular Therapy - Methods and Clinical Development, 2021, 22, pp. 76–83;
4) DE BELLIS ELEONORA:
Pubblicazioni:
- " Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD–positive acute myeloid leukemia ", Lo Iudice, G., De Bellis, E., Savi, A., ...Voso, M.T., Ciliberto, G., Journal of Translational Medicine, 2022, 20(1), 311;
- " Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy ",Voso, M.-T., Pandzic, T., Falconi, G., ...Fabiani, E., Baliakas, P., British Journal of Haematology, 2022, 198(1), pp. 103–113;
-" Vitamin C Deficiency in Patients With Acute Myeloid Leukemia " , Ottone, T., Faraoni, I., Fucci, G., ...Venditti, A., Voso, M.T., Frontiers in Oncology, 2022, 12, 890344;
- " Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol ",Messina, M., Piciocchi, A., Ottone, T., ...Martinelli, G., Voso, M.T., Cancers, 2022, 14(12), 3012;
- " Corrigendum: “Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience ”, De Bellis, E., Imbergamo, S., Candoni, A., ...Palmieri, C., Zaja, F., Leukemia Research, 2022, 115, 106811;
- " Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience ", De Bellis, E., Imbergamo, S., Candoni, A., ...Palmieri, C., Zaja, F., Leukemia Research, 2022, 114, 106803;
- " Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters ", Gurnari, C., Breccia, M., Di Giuliano, F., ...Garaci, F., Voso, M.T., British Journal of Haematology, 2021, 193(1), pp. 129–132;
- " Diagnosis and Classification of AML: WHO 2016 ", Voso, M.T., De Bellis, E., Ottone, T., Hematologic Malignancies, 2021, pp. 23–54;
5) GUERCIO MARIKA :
Pubblicazioni:
- " Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia ", Caruso, S., De Angelis, B., Del Bufalo, F., ...Locatelli, F., Quintarelli, C., Journal of Hematology and Oncology, 2022, 15(1), 163;
- " T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies ", Pulvirenti, F., Di Cecca, S., Sinibaldi, M., ...Carsetti, R., Quinti, I., Cells, 2022, 11(12), 1918;
- " B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies ", Pulvirenti, F., Salinas, A.F., Milito, C., ...Carsetti, R., Quinti, I., Cells, 2021, 10(11), 2915;
- " SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best ", Salinas, A.F., Mortari, E.P., Terreri, S., ...Carsetti, R., Quinti, I., Journal of Clinical Immunology, 2021, 41(8), pp. 1709–1722;
- " Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies ", Guercio, M., Manni, S., Boffa, I., ...Quintarelli, C., Locatelli, F., Frontiers in Immunology, 2021, 12, 755639;
- " Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts ", Quintarelli, C., Guercio, M., Manni, S., ...De Angelis, B., Locatelli, F., Journal for ImmunoTherapy of Cancer, 2021, 9(6), 001514;
- " CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and ", Guercio, M., Orlando, D., Cecca, S.D., ...Quintarelli, C., de Angelis, B., Haematologica, 2021, 106(4), pp. 987–999;
6) GURNARI CARMELO:
Mobilità:
- Progetti non EU - Cleveland Clinic Foundation, STATI UNITI D'AMERICA ( dal 01/11/2020 al 31/10/2021);
Pubblicazioni:
- " Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value ", Pagliuca, S., Gurnari, C., Zhang, K., ...Wang, L., Visconte, V., International Journal of Molecular Sciences, 2022, 23(23), 14885;
- " Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder ", Markouli, M., Ullah, F., Omar, N., ...Ahmed, S., Dima, D., Cancers, 2022, 14(23), 5949;
- " Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia ", Kubota, Y., Zawit, M., Durrani, J., ...Haferlach, T., Maciejewski, J.P., Leukemia, 2022, 36(12), pp. 2827–2834;
- " Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia ", Huuhtanen, J., Bhattacharya, D., Lönnberg, T., ...Kelkka, T., Mustjoki, S., Nature Communications, 2022, 13(1), 1981;
- " Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes ", Woerner, J., Huang, Y., Hutter, S., ...Haferlach, T., LaFramboise, T., Nature Communications, 2022, 13(1), 1038;
- " Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience ", Paterno, G., Palmieri, R., Forte, V., ...Venditti, A., Del Principe, M.I., Cancers, 2022, 14(22), 5640;
- " LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence ", Calabretto, G., Attardi, E., Gurnari, C., ...Voso, M.T., Zambello, R., Cancers, 2022, 14(21), 5236;
- " Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT ", Gurnari, C., McLornan, D.P., Bone Marrow Transplantation, 2022, 57(11), pp. 1642–1648;
- " Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes ", Hong, S., Rybicki, L., Gurnari, C., ...Patel, B.J., Maciejewski, J.P., Bone Marrow Transplantation, 2022, 57(10), pp. 1615–1619;
- " A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia ",Gurnari, C., Wahida, A., Pagliuca, S., ...Maciejewski, J.P., Visconte, V., Hematological Oncology, 2022, 40(4), pp. 812–817;
- " Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond ", Pagliuca, S., Gurnari, C., Rubio, M.T., Visconte, V., Lenz, T.L., Frontiers in Immunology, 2022, 13, 944872;
- " A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges ", Awada, H., Mustafa Ali, M.K., Thapa, B., ...Wang, E., Baer, M.R., Cancers, 2022, 14(17), 4166;
- " Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide ", Gurnari, C., Piciocchi, A., Soddu, S., ...Breccia, M., Voso, M.T., Blood Cancer Journal, 2022, 12(9), 132;
- " Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms ", Kongkiatkamon, S., Terkawi, L., Guan, Y., ...Jha, B.K., Maciejewski, J.P., Leukemia, 2022, 36(8), pp. 2086–2096;
- " The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia ", Travaglini, S., Gurnari, C., Antonelli, S., ...Ottone, T., Voso, M.T., Frontiers in Cell and Developmental Biology, 2022, 10, 930205;
- " Vitamin C Deficiency in Patients With Acute Myeloid Leukemia ", Ottone, T., Faraoni, I., Fucci, G., ...Venditti, A., Voso, M.T., Frontiers in Oncology, 2022, 12, 890344;
- " Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy ", Liu, Y.-C., Kwon, J., Fabiani, E., ...Tenen, D.G., Chai, L., New England Journal of Medicine, 2022, 386(21), pp. 1998–2010;
- " Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia ",Kongkiatkamon, S., Pagliuca, S., Adema, V., ...Visconte, V., Maciejewski, J.P., Leukemia, 2022, 36(4), pp. 1185–1188;
- " Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes ", Awada, H., Gurnari, C., Durmaz, A., ...Pagliuca, S., Visconte, V., International Journal of Molecular Sciences, 2022, 23(5), 2802;
- " T-cell large granular lymphocytic leukemia associated with inclusion body myositis ", Gurnari, C., Yeaney, G.A., Kalinowski, M., Cotta, C.V., Maciejewski, J.P., International Journal of Laboratory Hematology, 2022, 44(1), pp. 27–28;
- " Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation ", Nguyen, N., Gudmundsson, K.O., Soltis, A.R., ...Dalgard, C.L., Du, Y.,iScience, 2022, 25(1), 103679;
- " TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes ", Gurnari, C., Pagliuca, S., Guan, Y., ...Maciejewski, J.P., Visconte, V., Blood Advances, 2022, 6(1), pp. 100–107;
- " Molecular landscape of immune pressure and escape in aplastic anemia ", Pagliuca, S., Gurnari, C., Hercus, C., ...Haferlach, T., Maciejewski, J.P., Leukemia, 2022;
- " Aplastic anemia: Quo vadis? ", Gurnari, C., Maciejewski, J.P., Seminars in Hematology, 2022, 59(1), pp. 54–55;
- " What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children? ", Gurnari, C., Divona, M., Voso, M.T., Expert Opinion on Pharmacotherapy, 2022, 23(3), pp. 289–294;
- " We cannot paint them all with the same brush’: the need for a better definition of patients with myelodysplastic syndromes for clinical trial design ", Gurnari, C., Visconte, V., British Journal of Haematology, 2022, 196(2), pp. 268–269;
- " The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders ", Pagliuca, S., Gurnari, C., Awada, H., ...Lenz, T.L., Maciejewski, J.P., Blood, 2021, 138(26), pp. 2781–2798;
- " Have we reached a molecular era in myelodysplastic syndromes? ", Voso, M.T., Gurnari, C., Hematology (United States), 2021, 2021(1), pp. 418–427;
- " Alternative splicing in myeloid malignancies ", Gurnari, C., Pagliuca, S., Visconte, V., Biomedicines, 2021, 9(12), 1844;
- " Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia ", Awada, H., Durmaz, A., Gurnari, C., ...Haferlach, T., Maciejewski, J.P., Blood, 2021, 138(19), pp. 1885–1895;
- " Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia ", Chlon, T.M., Stepanchick, E., Hershberger, C.E., ...Maciejewski, J.P., Starczynowski, D.T., Cell Stem Cell, 2021, 28(11), pp. 1966–1981.e6;
- " Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria ", Gurnari, C., Pagliuca, S., Kewan, T., ...Visconte, V., Maciejewski, J.P., Blood Cancer Journal, 2021, 11(11), 187;
- " Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander? ", Gurnari, C., Pagliuca, S., Awada, H., ...Rogers, H.J., Maciejewski, J.P., Blood Cells, Molecules, and Diseases, 2021, 91, 102595;
- " Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations ", Awada, H., Kerr, C.M., Durmaz, A., ...Maciejewski, J.P., Visconte, V., Leukemia, 2021, 35(11), pp. 3324–3328;
- " Pegcetacoplan versus Eculizumab in PNH ", Gurnari, C., Pagliuca, S., Maciejewski, J.P., The New England journal of medicine, 2021, 385(18), pp. 1725;
- " Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML ", Trinh, B.Q., Ummarino, S., Zhang, Y., ...Di Ruscio, A., Tenen, D.G., Blood, 2021, 138(15), pp. 1331–1344;
- " Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants ", Cicconi, L., Testi, A.M., Montesinos, P., ...Lo-Coco, F., Abla, O., Blood Cancer Journal, 2021, 11(10), 167;
- " Chronic Budd–Chiari syndrome in paroxysmal nocturnal haemoglobinuria ", Gurnari, C., Colak, C., Zawit, M., Maciejewski, J.P., The Lancet, 2021, 398(10304), pp. e14;
- " A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia ", Zawit, M., Gurnari, C., Pagliuca, S., ...Maciejewski, J.P., Saunthararajah, Y., Clinical Case Reports, 2021, 9(9), e04533;
- " Large granular lymphocytic leukemia: From immunopathogenesis to treatment of refractory disease ", Zawit, M., Bahaj, W., Gurnari, C., Maciejewski, J., Cancers, 2021, 13(17), 4418;
- " Copper deficiency ", Gurnari, C., Rogers, H.J., New England Journal of Medicine, 2021, 385(7), pp. 640;
- " A comprehensive review of the genomics of multiple myeloma: Evolutionary trajectories, gene expression profiling, and emerging therapeutics ", Awada, H., Thapa, B., Awada, H., ...Hari, P., Dhakal, B., Cells, 2021, 10(8), 1961;
- " Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinurian ", Gurnari, C., Pagliuca, S., Patel, B.J., ...Visconte, V., Maciejewski, J.P., Leukemia, 2021, 35(8), pp. 2431–2434;
- " Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation ", Pagliuca, S., Gurnari, C., Hong, S., ...Hamilton, B.K., Maciejewski, J.P., JCI Insight, 2021, 6(13), e149080;
- " Vacuolization of hematopoietic precursors: an enigma with multiple etiologies ", Gurnari, C., Pagliuca, S., Durkin, L., ...Visconte, V., Maciejewski, J.P., Blood, 2021, 137(26), pp. 3685–3689;
- " Novel invariant features of Good syndrome ", Gurnari, C., Durrani, J., Pagliuca, S., ...Cook, J.R., Maciejewski, J.P., Leukemia, 2021, 35(6), pp. 1792–1796;
- " Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia ", Awada, H., Durmaz, A., Gurnari, C., ...Pagliuca, S., Visconte, V., Blood Cells, Molecules, and Diseases, 2021, 88, 102549;
- " How I manage acquired pure red cell aplasia in adults ", Gurnari, C., Maciejewski, J.P., Blood, 2021, 137(15), pp. 2001–2009;
- " Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters ", Gurnari, C., Breccia, M., Di Giuliano, F., ...Garaci, F., Voso, M.T., British Journal of Haematology, 2021, 193(1), pp. 129–132;
- " The interactome between metabolism and gene mutations in myeloid malignancies ", Gurnari, C., Pagliuca, S., Visconte, V., International Journal of Molecular Sciences, 2021, 22(6), pp. 1–16, 3135;
- " Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria ", Gurnari, C., Graham, A.C., Efanov, A., ...Sekeres, M.A., Maciejewski, J.P., Blood Cells, Molecules, and Diseases, 2021, 87, 102528;
- " Molecular targeted therapy in myelodysplastic syndromes: New options for tailored treatments ", Pagliuca, S., Gurnari, C., Visconte, V., Cancers, 2021, 13(4), pp. 1–22, 784;
- " From clonal hematopoiesis to therapy-related myeloid neoplasms: The silent way of cancer progression ", Gurnari, C., Fabiani, E., Falconi, G., ...Cristiano, A., Voso, M.T., Biology, 2021, 10(2), pp. 1–14, 128;
- " Acute promyelocytic leukemia in children: A model of precision medicine and chemotherapy-free therapy ", Gurnari, C., Voso, M.T., Girardi, K., Mastronuzzi, A., Strocchio, L., International Journal of Molecular Sciences, 2021, 22(2), pp. 1–13, 642;
- " Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria ", Gurnari, C., Nautiyal, I., Pagliuca, S., Therapeutics and Clinical Risk Management, 2021, 17, pp. 1343–1351;
- " Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols ", Rosati, S., Gurnari, C., Breccia, M., ...Voso, M.T., Latagliata, R., Acta Oncologica, 2021, 60(11), pp. 1520–1526;
8) HAJRULLAJ HAJRO:
Pubblicazioni:
- " Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis ", Falconi, Giuliaa; Galossi, Elisaa; Fabiani, Emilianoa, b;… Hajrullaj, Hajroa, Voso, M.T, Nature Research, 2022;
9) MARASCO EMILIANO:
Pubblicazioni:
- " Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification", Marasco, E., Mucke, J., Suurmond, J., Frontiers in Medicine, 2022, 9, 1085719;
- " An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations ", Fredi, M., Cavazzana, I., Ceribelli, A., ...Gerli, R., Franceschini, F., Clinical Reviews in Allergy and Immunology, 2022, 63(2), pp. 240–250;
- " Targeting interferon-γ in hyperinflammation: opportunities and challenges ", De Benedetti, F., Prencipe, G., Bracaglia, C., Marasco, E., Grom, A.A., Nature Reviews Rheumatology, 2021, 17(11), pp. 678–691;
- " The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: Results from the EUSTAR cohort ", Lazzaroni, M.-G., Marasco, E., Campochiaro, C., ...Allanore, Y., Airò, P., Rheumatology (Bulgaria), 2021, 60(11), pp. 5028–5041
- " Denosumab for the treatment of hiv-associated osteoporosis with fractures in a premenopausal woman ", Marasco, E., Mussa, M., Motta, F., ...Montecucco, C., Bogliolo, L., Reumatismo, 2021, 73(1), pp. 54–58;
10) PASCUCCI GIUSEPPE RUBENS:
Pubblicazioni:
- " Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity ", Morrocchi, E., Pighi, C., Pascucci, G.R., ...Levy, O., Palma, P., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 75(1), pp. S51–S60;
- " The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection ", Romani, L., Del Chierico, F., Macari, G., ...Palma, P., Putignani, L., Frontiers in Cellular and Infection Microbiology, 2022, 12, 908492;
- " Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens ", Cotugno, N., Franzese, E., Angelino, G., ...De Angelis, P., Palma, P., Vaccines, 2022, 10(7), 1109;
- " Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy ", Ruggiero, A., Pascucci, G.R., Cotugno, N., ...Pahwa, S., Palma, P., Frontiers in Immunology, 2022, 13, 860418;
- " A Parallel Tracking of Salivary and Gut Microbiota Profiles Can Reveal Maturation and Interplay of Early Life Microbial Communities in Healthy Infants ", Reddel, S., Pascucci, G.R., Foligno, S., ...Salvatori, G., Putignani, L., Microorganisms, 2022, 10(2), 468;
- " Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology ", Cotugno, N., Ruggiero, A., Pascucci, G.R., ...degli Atti, M.C., D'Amore, C., Pediatric Allergy and Immunology, 2021, 32(8), pp. 1833–1842;
- " Antibiotics treatment modulates microglia–synapses interaction ", Cordella, F., Sanchini, C., Rosito, M., ...Ragozzino, D., Di Angelantonio, S., Cells, 2021, 10(10), 2648;
- " Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) ", Doria, M., Zicari, S., Cotugno, N., ...Pahwa, S., Palma, P., Journal of the International AIDS Society, 2021, 24(7), e25717;
- " Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies", Cotugno, N., Ruggiero, A., Bonfante, F., ...De Rossi, A., Palma, P., Cell Reports, 2021, 34(11), 108852;
11) SGRULLETI MAYLA
Pubblicazioni:
- "Secondary rituximab-associated versus primary immunodeficiencies: The enigmatic border ", Ottaviano, G., Sgrulletti, M., Moschese, V., European Journal of Immunology, 2022, 52(10), pp. 1572–1580;
- " Vaccinations in Children and Adolescents Treated With Immune-Modifying Biologics: Update and Current Developments ", Martire, B., Ottaviano, G., Sangerardi, M., ...Marseglia, G.L., Moschese, V., Journal of Allergy and Clinical Immunology: In Practice, 2022, 10(6), pp. 1485–1496;
- " Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease ", Doria, M., Moscato, G.M.F., Di Cesare, S., ...Marin-Esteban, V., Moschese, V., Frontiers in Immunology, 2022, 13, 799564;
- " Novel artful applications of vaccines at the horizon ", Montin, D., Ottaviano, G., Sangerardi, M., ...Rizzo, C., Moschese, V., Pediatric Allergy and Immunology, 2022, 33(S27), pp. 83–85;
- " Pediatric health care professionals’ vaccine knowledge, awareness and attitude: a survey within the Italian Society of Pediatric Allergy and Immunology ", Del Duca, E., Chini, L., Graziani, S., ...Duse, M., Marseglia, G., Italian Journal of Pediatrics, 2021, 47(1), 183;
- " Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies ", Amodio, D., Ruggiero, A., Sgrulletti, M., ...Moschese, V., Palma, P., Frontiers in Immunology, 2021, 12, 727850;
- " The Protective Role of Maternal Immunization in Early Life ", Cinicola, B., Conti, M.G., Terrin, G., ...Moschese, V., Duse, M., Frontiers in Pediatrics, 2021, 9, 638871;
- " IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infections ", , Cavaliere, F.M., Graziani, S., Del Duca, E., ...Quinti, I., Moschese, V. , Scandinavian Journal of Immunology, 2021, 93(1), e12955;
1) BEATRICE RIVALTA:
Pubblicazioni:
- " Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report ", Di Lorenzo, B., Pacillo, L., Milardi, G., ...Cancrini, C., Fousteri, G., Frontiers in Immunology, 2022, 13, 952715;
- " Targeted treatment of autoimmune cytopenias in primary immunodeficiencies ", Pacillo, L., Giardino, G., Amodio, D., ...Finocchi, A., Cancrini, C., Frontiers in Immunology, 2022, 13, 911385;
- " SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity ", Conti, F., Pacillo, L., Amodio, D., ...Pession, A., Finocchi, A., Pediatric Allergy and Immunology, 2022, 33(8), e13833;
- " Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? ", Chiriaco, M., Ursu, G.M., Amodio, D., ...Di Matteo, G., Cancrini, C., Frontiers in Immunology, 2022, 13, 919237;
- " The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) ", Giardino, G., Milito, C., Lougaris, V., ...Quinti, I., Pignata, C., Journal of Clinical Immunology, 2022, 42(5), pp. 935–946;
- " Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment ", Rivalta, B., Amodio, D., Giancotta, C., ...Cancrini, C., Palma, P., Frontiers in Immunology, 2022, 13, 891274;
- " Biallelic CLPB mutation associated with isolated neutropenia and 3-MGA-uria ", Rivalta, B., Torraco, A., Martinelli, D., ...Carrozzo, R., Finocchi, A., Pediatric Allergy and Immunology, 2022, 33(5), e13782;
- " Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network ", , Cirillo, E., Polizzi, A., Soresina, A., ...Chessa, L., Pignata, C., Journal of Clinical Immunology, 2022, 42(4), pp. 783–797;
- " Host Defenses to Viruses: Lessons from Inborn Errors of Immunity ", Leonardi, L., Rivalta, B., Leone, F., ...Marseglia, G.L., Cardinale, F., Medicina (Lithuania), 2022, 58(2), 248;
- " Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature ", Marzollo, A., Conti, F., Rossini, L., ...Finocchi, A., Bresolin, S., Journal of Clinical Immunology, 2022, 42(2), pp. 299–311;
- " Activated phosphoinositide 3-dinase delta syndrome (APDS): An update ", Lougaris, V., Cancrini, C., Rivalta, B., ...Marseglia, G.L., Cardinale, F., Pediatric Allergy and Immunology, 2022, 33(S27), pp. 69–72;
- " Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients ", Cifaldi, C., Rivalta, B., Amodio, D., ...Finocchi, A., Cancrini, C., Journal of Clinical Immunology, 2022, 42(1), pp. 130–145;
- " Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies", Amodio, D., Ruggiero, A., Sgrulletti, M., ...Moschese, V., Palma, P. , Frontiers in Immunology, 2021, 12, 727850;
-" Corrigendum: Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient ", Conti, F., Catelli, A., Cifaldi, C., ...Cancrini, C., Pession, A. Frontiers in Pediatrics, 2021, 9, 757229;
- " Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up ", Rivalta, B., Amodio, D., Milito, C., ...Tommasini, A., Cancrini, C., Frontiers in Pediatrics, 2021, 9, 703853;
- " Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient ", Conti, F., Catelli, A., Cifaldi, C., ...Cancrini, C., Pession, A. , Frontiers in Pediatrics, 2021, 9, 702546;
- " Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity ", Milito, C., Lougaris, V., Giardino, G., ...Pignata, C., Quinti, I., Journal of Allergy and Clinical Immunology: In Practice, 2021, 9(7), pp. 2904–2906.e2;
- " Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration ", Zama, D., Conti, F., Moratti, M., ...Seri, M., Pession, A., Immunity, Inflammation and Disease, 2021, 9(2), pp. 583–594;
- " Update in primary immunodeficiencies ", Leonardi, L., Rivalta, B., Cancrini, C., ...Marseglia, G.L., Cardinale, F., Acta Biomedica, 2020, 91, pp. 1–6, e2020010;
2) PACILLO LUCIA:
Pubblicazioni:
- " Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report ", Di Lorenzo, B., Pacillo, L., Milardi, G., ...Cancrini, C., Fousteri, G., Frontiers in Immunology, 2022, 13, 952715;
- " Targeted treatment of autoimmune cytopenias in primary immunodeficiencies ", Pacillo, L., Giardino, G., Amodio, D., ...Finocchi, A., Cancrini, C., Frontiers in Immunology, 2022, 13, 911385;
- " SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity ", Conti, F., Pacillo, L., Amodio, D., ...Pession, A., Finocchi, A., Pediatric Allergy and Immunology, 2022, 33(8), e13833;
- " Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? ", Chiriaco, M., Ursu, G.M., Amodio, D., ...Di Matteo, G., Cancrini, C., Frontiers in Immunology, 2022, 13, 919237;
- " Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency ", Milardi, G., Di Lorenzo, B., Gerosa, J., ...Cicalese, M.P., Fousteri, G., European Journal of Immunology, 2022, 52(7), pp. 1171–1189;
- " Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment ", Rivalta, B., Amodio, D., Giancotta, C., ...Cancrini, C., Palma, P., Frontiers in Immunology, 2022, 13, 891274;
- " In Search for the Missing Link in APECED-Like Conditions: Analysis of the AIRE Gene in a Series of 48 Patients ", Fierabracci, A., Belcastro, E., Carbone, E., ...Cappa, M., Betterle, C., Journal of Clinical Medicine, 2022, 11(11), 3242;
- " Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients ", Cifaldi, C., Rivalta, B., Amodio, D., ...Finocchi, A., Cancrini, C., Journal of Clinical Immunology, 2022, 42(1), pp. 130–145;
- " Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies ", Amodio, D., Ruggiero, A., Sgrulletti, M., ...Moschese, V., Palma, P., Frontiers in Immunology, 2021, 12, 727850;
- " Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up ", Rivalta, B., Amodio, D., Milito, C., ...Tommasini, A., Cancrini, C., Frontiers in Pediatrics, 2021, 9, 703853;
- " Urogenital Abnormalities in Adenosine Deaminase Deficiency ", Pajno, R., Pacillo, L., Recupero, S., ...Booth, C., Aiuti, A., Journal of Clinical Immunology, 2020, 40(4), pp. 610–618;